Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Rhizen Pharmaceuticals Sa

Clinical trials sponsored by Rhizen Pharmaceuticals Sa, explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

New hope for Hard-to-Treat breast cancer: drug trial targets advanced TNBC Results expected Dec 2026 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 1

New hope for Hard-to-Treat breast cancer: drug trial targets advanced TNBC

Disease control Recruiting now

This study tests a new drug called tenalisib in 40 people with metastatic triple negative breast cancer (TNBC) who have already tried 1 to 3 other treatments. The goal is to see if tenalisib can shrink tumors or stop them from growing for at least 16 weeks. Researchers will also …

Phase 2 • Sponsor: Rhizen Pharmaceuticals SA • Aim: Disease control

Last updated Jun 27, 2026 08:01 UTC